Curaleaf Holdings, a vertically integrated cannabis operator in the United States, will today (Oct 29) begin trading on the Canadian Securities Exchange under the ticker symbol “CURA”.
In connection with the listing, Curaleaf raised approximately C$520 million (US$400 million) in an oversubscribed private placement offering led by GMP Securities L.P. and Canaccord Genuity Corp., on behalf of a syndicate of agents, including Cormark Securities Inc., Eight Capital and Haywood Securities Inc.
The company said that the offering marked the largest cannabis equity financing completed to date.
“Listing on the Canadian Securities Exchange is a critical step in our growth trajectory. We are excited to make our mark within cannabis financing history through the overwhelming support of over 100 institutions internationally,” said Joseph Lusardi, CEO of Curaleaf (pictured)
“We remain committed to growing our business through aggressive organic growth and the strategic deployment of capital into accretive acquisitions that extend our brand into the most attractive U.S. markets.”
“Listing on the Canadian Securities Exchange is a critical step in our growth trajectory.”
Joseph Lusardi, Curaleaf (pictured)
Curaleaf has a footprint that spans 12 U.S. states, comprising 28 dispensaries, 12 cultivation facilities and 9 processing sites.
The company, including subsidiaries and managed entities, operates in Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon, with licensing pending in California and Pennsylvania.
Through its team of physicians, pharmacists, medical experts and industry visionaries, the Company has developed the Curaleaf brand, a premium mainstream cannabis brand available in multiple states and product formats through its network of branded retail dispensaries.
Curaleaf Holdings, Inc. is the parent of Curaleaf, Inc., is a leading vertically integrated cannabis operator in the United States, headquartered in Wakefield, Massachusetts.Cannabis Business Worldwide